You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Single Doses

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atherosclerosis, Ischemic Stroke Trial in Nottingham (SP-8356, Placebo)

Terminated
  • Atherosclerosis
  • Ischemic Stroke
  • Nottingham, Mere Way Ruddington Fields Ruddington, United Kingdom
    Quotient Sciences
Oct 6, 2022

Healthy Trial in London (Pozelimab, Cemdisiran)

Completed
  • Healthy
  • London, United Kingdom
    Regeneron Research Site
Jul 1, 2022

Healthy Trial (BI 1015550, Moxifloxacin, Placebo)

Not yet recruiting
  • Healthy
  • BI 1015550
  • +2 more
  • (no location specified)
Nov 2, 2023

Healthy Female Participants Trial in Brooklyn (Zibotentan, EE/LNG)

Not yet recruiting
  • Healthy Female Participants
  • Brooklyn, Maryland
    Research Site
Aug 16, 2022

Health Volunteers Trial in Miami (Midazolam, CTP-543)

Completed
  • Health Volunteers
  • Miami, Florida
    Clinical Pharmacology of Miami, LLC
Jul 18, 2022

Contrast Enhancement in Magnetic Resonance Imaging, Healthy Volunteers Trial in Fukuoka (BAY1747846, Matching )

Completed
  • Contrast Enhancement in Magnetic Resonance Imaging
  • Healthy Volunteers
  • Fukuoka, Japan
    SOUSEIKAI Fukuoka Mirai Hospital
Nov 6, 2023

Chronic Leg Ulcer, Venous Leg Ulcer Trial in Copenhagen (SoftOx Biofilm Eradicator (Groups 1 to 7), Sterile isotonic saline

Completed
  • Chronic Leg Ulcer
  • Venous Leg Ulcer
  • SoftOx Biofilm Eradicator (Groups 1 to 7)
  • Sterile isotonic saline (Groups 1 to 4)
  • Copenhagen, Denmark
    Bispebjerg University Hospital
Jan 24, 2023

Healthy Trial in New Haven (PF-07328948, Placebo)

Recruiting
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 5, 2023

Contrast Enhancement in Magnetic Resonance Imaging, Healthy Volunteers Trial in Beijing (Gadoquatrane (BAY1747846) 0.03 mmol

Completed
  • Contrast Enhancement in Magnetic Resonance Imaging
  • Healthy Volunteers
  • Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg
  • +2 more
  • Beijing, China
    Beijing Hospital
Nov 13, 2023

Safety Trial in Tempe (SBT115301, Placebo)

Recruiting
  • Safety
  • SBT115301
  • Placebo
  • Tempe, Arizona
    Celerion
Aug 2, 2022

Systemic Lupus Erythematosus, Healthy Volunteers Trial in United States (BIIB059, Placebo)

Completed
  • Systemic Lupus Erythematosus
  • Healthy Volunteers
  • BIIB059 (litifilimab)
  • Placebo
  • Anniston, Alabama
  • +4 more
Jan 30, 2023

Cystic Fibrosis Trial in Christchurch (ARCT-032, Placebo)

Not yet recruiting
  • Cystic Fibrosis
  • Christchurch, New Zealand
    New Zealand Clinical Research
Feb 3, 2023

Chronic Hepatitis B Trial in Worldwide (ALG-125755, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Sofia, Bulgaria
  • +3 more
Oct 28, 2022

Healthy Participants Trial (BMS-986454, Placebo)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Oct 11, 2023

Healthy Trial (BI 1584862, Placebo)

Not yet recruiting
  • Healthy
  • BI 1584862
  • Placebo
  • (no location specified)
Dec 1, 2023

Myoclonus Epilepsies, Progressive Trial in Philadelphia (AUT00201, Placebo)

Recruiting
  • Myoclonus Epilepsies, Progressive
  • Philadelphia, Pennsylvania
    University of Pennsylvania, Penn Epilepsy Center
May 15, 2023

Alzheimer's Disease Trial (CS6253 Solution for Injection, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • CS6253 Solution for Injection
  • Placebo
  • (no location specified)
Jul 20, 2023

Male Contraception Trial (YCT-529, YCT-529 Placebo)

Not yet recruiting
  • Male Contraception
  • (no location specified)
Oct 16, 2023

Healthy Trial (BI 3802876, Placebo matching BI 3802876)

Not yet recruiting
  • Healthy
  • BI 3802876
  • Placebo matching BI 3802876
  • (no location specified)
Oct 16, 2023

Healthy Trial in Tokyo, Shinjuku-ku (BI 765845, Placebo)

Active, not recruiting
  • Healthy
  • BI 765845
  • Placebo
  • Tokyo, Shinjuku-ku, Japan
    Clinical Research Hospital Tokyo
Nov 15, 2023

Hyperlipemia Trial in Beijing (RBD7022, Placebo)

Recruiting
  • Hyperlipemia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 12, 2023

Healthy Trial (BI 1839100, Placebo matching BI 1839100)

Not yet recruiting
  • Healthy
  • BI 1839100
  • Placebo matching BI 1839100
  • (no location specified)
Jul 11, 2023

Neuroinflammatory Response Trial in Groningen (MT1980, Placebo)

Recruiting
  • Neuroinflammatory Response
  • Groningen, Netherlands
    Icon Early Development Services
Jun 22, 2022

Inflammation Trial in Montréal (Avenanthramide, Placebo)

Not yet recruiting
  • Inflammation
  • MontrĂ©al, Quebec, Canada
    Montreal Heart Institute
Oct 24, 2023

Healthy Subjects Trial (TLC-6740, Placebo)

Not yet recruiting
  • Healthy Subjects
  • (no location specified)
Apr 19, 2023